Alliance Pharma PLC has received a notification of major holdings from Slater Investments. The reason for the notification is an acquisition or disposal of voting rights. Slater Investments, based in London, holds a total of 10.02% of voting rights in Alliance Pharma PLC. This consists of 2,703,872 direct voting rights and 51,418,909 indirect voting rights. The total number of voting rights held by Slater Investments is 54,122,781. The notification was made on September 21, 2023, and the issuer was notified on September 22, 2023. The notification also includes information about the ultimate controlling person, Mark Slater, and his controlled undertaking, Slater Investments. The notification does not mention any proxy voting. The completion date of the notification is September 22, 2023.